(Q37979871)

26 August 2017

title

A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia (English)

1 reference

26 August 2017

Luc Staner

1

1 reference

26 August 2017

Philippe Danjou

series ordinal

2

1 reference

26 August 2017

Remy Luthringer

series ordinal

3

1 reference

26 August 2017

publication date

1 February 2012

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

26 August 2017

published in

1 reference

26 August 2017

volume

12

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

141-153

1 reference

Epidemiology of insomnia: what we know and what we still need to learn

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Insomnia and the eye of the beholder: are there clinical markers of objective sleep disturbances among adults with and without insomnia complaints?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Clinical correlates of insomnia in patients with chronic illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Sleep deprivation and pain perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Effects of sleep deprivation and exercise on cognitive, motor performance and mood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Comorbidity of insomnia and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Insomnia and its treatment. Prevalence and correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

On the comparability of pharmacotherapy and behavior therapy for chronic insomnia. Commentary and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Effect of zolpidem on sleep in insomniac patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Abolition of zolpidem sensitivity in mice with a point mutation in the GABAA receptor gamma2 subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Loss of zolpidem efficacy in the hippocampus of mice with the GABAA receptor gamma2 F77I point mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Structural determinants for high-affinity zolpidem binding to GABA-A receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

GABAA receptor subtypes immunopurified from rat brain with α subunit-specific antibodies have unique pharmacological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Mechanism of action of the hypnotic zolpidem in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

GABA-based therapeutic approaches: GABAA receptor subtype functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Discriminative stimulus effects of zolpidem in squirrel monkeys: role of GABA(A)/alpha1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Comparative cue generalization profiles of L-838, 417, SL651498, zolpidem, CL218,872, ocinaplon, bretazenil, zopiclone, and various benzodiazepines in chlordiazepoxide and zolpidem drug discrimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Do subtype-selective gamma-aminobutyric acid A receptor modulators have a reduced propensity to induce physical dependence in mice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Deletion of the alpha1 or beta2 subunit of GABAA receptors reduces actions of alcohol and other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

GABAA/alpha1 receptor agonists and antagonists: effects on species-typical and heightened aggressive behavior after alcohol self-administration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Which GABAA-receptor subtypes really occur in the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

The sleep switch: hypothalamic control of sleep and wakefulness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

The role of histamine and the tuberomamillary nucleus in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

GABA(A) receptor heterogeneity in histaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Sleep EEG changes after zolpidem in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

The modulation of synaptic GABA(A) receptors in the thalamus by eszopiclone and zolpidem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Zolpidem: a review of its use in the management of insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Dynamics and kinetics of a modified-release formulation of zolpidem: comparison with immediate-release standard zolpidem and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Clinically Important Drug Interactions with Zopiclone, Zolpidem and Zaleplon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Zolpidem pharmacokinetic properties in young females: influence of smoking and oral contraceptive use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Pharmacokinetics of two lorazepam formulations, oral and sublingual, after multiple doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Relative bioavailability of midazolam following sublingual versus oral administration in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Central nervous system side effects associated with zolpidem treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Hypnosedative-induced complex behaviours : incidence, mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Hyperarousal and insomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

The hyperarousal model of insomnia: a review of the concept and its evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Sleep homeostasis in primary insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

The safety and efficacy of zolpidem in insomniac patients: a long-term open study in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

'As-needed' prescription of zolpidem for insomnia in routine general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Zaleplon: a review of its use in the treatment of insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Polysomnographic study of intermittent zolpidem treatment in primary sleep maintenance insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Gradual withdrawal of zopiclone (7.5 mg) and zolpidem (10 mg) in insomniacs treated for at least 3 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

Safety and tolerance of zolpidem in the treatment of disturbed sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.197

21 January 2018

Identifiers

DOI

10.1586/ERN.11.197

1 reference

26 August 2017

1 reference